ArticleBMC cancer2025
Global, regional, and national burden of colorectal cancer among women of childbearing age from 1990 to 2021: a systematic analysis based on the global burden of disease study 2021.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Injury Burden in India, 1990 to 2023: National and Subnational Trends From the Global Burden of Disease 2023 Study.Cureus · 2026Article
- Female Oncofertility in Colorectal Cancer: Reproductive Uncertainties and Potential Benefits of Immunotherapy.Journal of clinical medicine · 2026Review
- Searching for Novel Molecular Prognostic Markers in Colorectal Cancer-The Tumor Suppressor Proteins p53 and PTEN.Biomedicines · 2026Article
- Burdens of Gastroesophageal Reflux Disease in China: Findings from the 2021 GBD Study.PloS one · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeColorectal cancer treatment measures can lead to reduced fertility and premature ovarian failure in women of childbearing age (WCBA), resulting in a major global burden. This study aimed to assess the global, regional and national burden of colorectal cancer (CRC) in WCBA and to provide the most up-to-date and comprehensive information available on WCBA CRC.
methodsFour main indicators, including prevalence, incidence, mortality, and DALYs, related to CRC in WCBA were extracted from the Global Burden of Disease (GBD) database from 1990 to 2021. The Joinpoint regression was used to analyse the temporal trend. The slope index and concentration index were employed to evaluate cross-country inequality, and Frontier analysis was conducted to assess efficiency.
resultsIn 2021, the global prevalence, incidence, deaths and DALYs cases of CRC among WCBA were 2 times, 1.7 times, 1.2 times, and 1.2 times, respectively, compared to 1990. Over the past 32 years, age-standardised prevalence rate (ASPR) has increased globally, while age-standardised incidence rate (ASIR), age-standardised mortality rate (ASMR) and age-standardised DALYs rate (ASDR) have shown a declining trend. Decomposition analysis indicated that population growth and ageing are the primary factors contributing to the rising burden. Furthermore, the concentration index and the analysis by the Social Development Index revealed that more developed regions experienced a higher burden.
conclusionsOverall, the burden of CRC among WCBA has significantly increased globally over the past 32 years, particularly within higher SDI regions and the 45-49 age group. Considering the rising trend, close cooperation between countries and rational screening procedures are essential to address the problems posed by CRC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.